Trillium Therapeutics Inc.

(TRIL)

By |

Profile

Trillium Therapeutics Inc is an immuno-oncology company developing therapies for the treatment of cancer. Its SIRPaFc and CD200 monoclonal antibody targets immuno regulatory pathways that tumor cells exploit to evade the host immune system.

Contact Information

Website: www.trilliumtherapeutics.com
Main Phone: +1 416 595-0627
Address: 2488 Dunwin Drive
State: ON
City / Town: Mississauga
Country: CAN
Postal Code: L5L 1J9

Issuer Information

Exchange: NSC
Employees: 28
NAICS: Pharmaceutical P
$ 6.90 ($ 0.30) (-4.17%)
Last Price 6.90 Change $ -0.30 Change % -4.17 Tick N/A
Bid 6.85 Bid Size 4,100.00 Ask 6.90 Ask Size 2,700.00
Open 7.10 High 7.25 Low 6.80 Prev Close 7.20
Last Trade Volume 234,226 52 Wk Hi 17.70 52 Wk Low 6.62
Market Cap 54.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 7,835,118.00 EPS (TTM) -1.73 PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 20 20 20 20
Low Target Price Estimate 18 18 20 18
Mean Target Price Estimate 19 19 20 19
Standard Deviation 1.41 1.41 0 1.41
Date of Most Recent Estimate 08/12/16 08/03/16 07/18/16 08/22/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 2 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1